China Pharma Holdings, Inc.CPHINYSE
Loading
Operating Expenses Over TimeExpanding
Percentile Rank60
3Y CAGR-1.8%
5Y CAGR-8.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-1.8%/yr
Annual compound
5Y CAGR
-8.6%/yr
Recent acceleration
Percentile
P60
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $2.90M | +11.3% |
| 2024 | $2.60M | +5.4% |
| 2023 | $2.47M | -19.1% |
| 2022 | $3.06M | -4.8% |
| 2021 | $3.21M | -29.2% |
| 2020 | $4.53M | -7.0% |
| 2019 | $4.87M | +139.2% |
| 2018 | $-12.42M | +41.3% |
| 2017 | $-21.15M | -85.9% |
| 2016 | $-11.37M | - |